Platelet transfusion alters CD40L blood level and release capacity in patients suffering from thrombocytopenia

Transfusion

Volumn 52, Issue 6, 2012, Pages 1213-1220

  Wenzel, Folker ^a   Gun̈ther, Wiebke ^a   Baertl, Anja ^a   Gruber, Wolfgang ^a   Sorg, RüdigerVolker ^a   Haas, Rainer ^a   Giers, Gun̈ther ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CHEMOTHERAPY; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HODGKIN DISEASE; HUMAN; LEUKOCYTE COUNT; MALE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOCYTOPHERESIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD DONORS; CASE-CONTROL STUDIES; CD40 LIGAND; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PLATELET COUNT; PLATELET TRANSFUSION; PLATELETPHERESIS; THROMBOCYTOPENIA;

EID: 84862264951     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03438.x     Document Type: Article

References (38)

1. Kaufman J, Spinelli SL, Schultz E, Blumberg N, Phipps RP. Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion. J Thromb Haemost 2007;5:788-96. (Pubitemid 46563579)
2. Zirlik A, Maier C, Gerdes N, MacFarlane L, Soosairajah J, Bavendiek U, Ahrens I, Ernst S, Bassler N, Missiou A, Patko Z, Aikawa M, Schönbeck U, Bode C, Libby P, Peter K. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 2007;115:1571-80. (Pubitemid 46648642)
3. Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, Libby P. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A 1997;94:1931-6. (Pubitemid 27113939)
4. Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 2002;8:247-52. (Pubitemid 34250102)
5. Tormey CA, Sweeney JD, Champion MH, Pisciotto PT, Snyder EL, Wu Y. Analysis of transfusion reactions associated with prestorage-pooled platelet components. Transfusion 2009;49:1242-7.
6. Keller-Stanislawski B, Lohmann A, Gunay S, Heiden M, Funk MB. The German Haemovigilance System - reports of serious adverse transfusion reactions between 1997 and 2007. Transfus Med 2009;19:340-9.
7. Pietersz RN. Pooled platelet concentrates: an alternative to single donor apheresis platelets? Transfus Apher Sci 2009;41:115-9.
8. Blumberg N, Gettings KF, Turner C, Heal JM, Phipps RP. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 2006;46:1813-21. (Pubitemid 44435735)
9. Aye MT, Palmer DS, Giulivi A, Hashemi S. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995;35:117-24.
10. Cognasse F, Payrat JM, Corash L, Osselaer JC, Garraud O. Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand. Blood 2008;112:4779-80; author reply 80-1.
11. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, Gettings KF, McLaughlin NJ, Silliman CC. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006;108:2455-62. (Pubitemid 44497533)
12. Wadhwa M, Seghatchian MJ, Lubenko A, Contreras M, Dilger P, Bird C, Thorpe R. Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays. Br J Haematol 1996;93:225-34. (Pubitemid 26130732)
13. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591-4. (Pubitemid 28157601)
14. Semple JW, Italiano JE Jr, Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011;11:264-74.
15. Choi WS, Jeon OH, Kim DS. CD40 ligand shedding is regulated by interaction of MMP-2 and platelet integrin alphaIIbbeta3. J Thromb Haemost 2010;8:1364-71.
16. Reinboldt S, Wenzel F, Rauch BH, Hohlfeld T, Grandoch M, Fischer JW, Weber AA. Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets. Platelets 2009;20:441-4.
17. Wenzel F, Gunther W, Baertl A, Lasshofer R, Rox J, Fischer JC, Giers G. Comparison of soluble CD40L concentrations and release capacities in apheresis and prestorage pooled platelet concentrates. Clin Hemorheol Microcirc 2011;47:269-78.
18. Anderson NA, Gray S, Copplestone JA, Chan DC, Hamon M, Prentice AG, Johnson SA, Phillips M, vanWaeg G, Oakhill A, Abeyasekera S, Pamphilon DH. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions. Transfus Med 1997;7:33-9. (Pubitemid 27141044)
19. Bishop JF, Matthews JP, Yuen K, McGrath K, Wolf MM, Szer J. The definition of refractoriness to platelet transfusions. Transfus Med 1992;2:35-41.
20. Guide to the preparation, use and quality assurance of blood components. 14th ed. Strasbourg: Council of Europe; 2008.
21. Standards for blood banks and transfusion services. 25th ed. Bethesda (MD): American Association of Blood Banks; 2008.
22. Haemonetics reference manual: Haemonetics MCS+, part no. 09000-220E/ED, Thrombozytenprotokoll Bedienungsanleitung Rev. A. 1997:1:68.
23. Bishop JF, Matthews JP, McGrath K, Yuen K, Wolf MM, Szer J. Factors influencing 20-hour increments after platelet transfusion. Transfusion 1991;31:392-6.
24. Ishida A, Handa M, Wakui M, Okamoto S, Kamakura M, Ikeda Y. Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation - a prospective analysis. Transfusion 1998;38:839-47. (Pubitemid 28421645)
25. Schonbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001;58:4-43. (Pubitemid 32143961)
26. Foy TM, Laman JD, Ledbetter JA, Aruffo A, Claassen E, Noelle RJ. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 1994;180:157-63. (Pubitemid 24181064)
27. Pradier O, Willems F, Abramowicz D, Schandené L, de Boer M, Thielemans K, Capel P, Goldman M. CD40 engagement induces monocyte procoagulant activity through an interleukin-10 resistant pathway. Eur J Immunol 1996;26:3048-54. (Pubitemid 26411512)
28. Miller DL, Yaron R, Yellin MJ. CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression. J Leukoc Biol 1998;63:373-9. (Pubitemid 28106852)
29. Prasad KS, Andre P, Yan Y, Phillips DR. The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease. Curr Opin Hematol 2003;10:356-61. (Pubitemid 36936607)
30. Cognasse F, Boussoulade F, Chavarin P, Acquart S, Fabrigli P, Lamy B, Garraud O. Release of potential immunomodulatory factors during platelet storage. Transfusion 2006;46:1184-9. (Pubitemid 44139493)
31. Apelseth TO, Hervig T, Wentzel-Larsen T, Petersen K, Reikvam H, Bruserud Ø. A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia. Eur Cytokine Netw 2011;22:52-62.
32. Phipps RP, Kaufman J, Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet 2001;357:2023-4. (Pubitemid 32592392)
33. Wenzel F, Baertl A, Zimmermann N, Hohlfeld T, Giers G, Oldenburg J, Assert R. Different behaviour of soluble CD40L concentrations can be reflected by variations of preanalytical conditions. Clin Hemorheol Microcirc 2008;39:417-22. (Pubitemid 352040027)
34. Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M, Fiocchi C. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2003;52:1435-41. (Pubitemid 37176723)
35. Curvers J, van Pampus EC, Feijge MA, Rombout- Sestrienkova E, Giesen PL, Heemskerk JW. Decreased responsiveness and development of activation markers of PLTs stored in plasma. Transfusion 2004;44:49-58. (Pubitemid 38177136)
36. Jung F, Seyfert UT. Efficacy of various blood bank filters for leukocyte depletion of red blood cell concentrates. Infusionsther Transfusionsmed 1998;25:312-6. (Pubitemid 28462196)
37. Schubert P, Devine DV. Towards targeting platelet storage lesion-related signaling pathways. Blood Transfus 2007;8 Suppl 3:s69-72.
38. Seyfert UT, Jung F. Platelet function testing in concentrates: comparison of apheresis concentrate (llaemapheresis) versus random platelet concentrate (quadruple bag). Clin Lab 1999;45:623-6.